RISPERDAL CONSTA

Janssen Pharmaceuticals, Inc.🇺🇸 United States

FDA Page

Effective Date: Feb 8, 2024
Approval ID: bb34ee82-d2c2-43b8-ba21-2825c0954691
Products: 4 registered
Version: 32

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use RISPERDAL CONSTA safely and effectively. See full prescribing information for RISPERDAL CONSTA RISPERDAL CONSTA (risperidone) LONG-ACTING INJECTION Initial U.S. Approval: 2003

Quick Stats

Total Products4

Labelers2

Label Sections43

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.